| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.80e-05 | 18 | 85 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.49e-04 | 118 | 85 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.26e-04 | 28 | 85 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.26e-04 | 70 | 85 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | transcription factor binding | EHMT2 KLF5 CD34 CTDP1 SRF NCOA1 CRTC1 FOXP1 RUNX3 MEF2A SMAD3 | 3.43e-04 | 753 | 85 | 11 | GO:0008134 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.21e-04 | 37 | 85 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 6.32e-04 | 9 | 85 | 2 | GO:0017151 | |
| GeneOntologyMolecularFunction | primary miRNA binding | 7.88e-04 | 10 | 85 | 2 | GO:0070878 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 8.20e-04 | 582 | 85 | 9 | GO:0140297 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity | 9.61e-04 | 11 | 85 | 2 | GO:0052629 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate phosphatase activity | 1.58e-03 | 14 | 85 | 2 | GO:0004438 | |
| GeneOntologyMolecularFunction | phosphatidylinositol monophosphate phosphatase activity | 1.81e-03 | 15 | 85 | 2 | GO:0052744 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.01e-03 | 417 | 85 | 7 | GO:0061629 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 2.04e-03 | 59 | 85 | 3 | GO:0001222 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 2.07e-03 | 16 | 85 | 2 | GO:0106018 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | 4.24e-06 | 391 | 84 | 10 | GO:0051146 | |
| GeneOntologyBiologicalProcess | muscle structure development | ANK2 ATG7 KLF5 CTDP1 ADGRB3 CASP1 SRF FOXP1 UNC45A MYO18B CDH2 UTRN MEF2A SMAD3 | 8.83e-06 | 858 | 84 | 14 | GO:0061061 |
| GeneOntologyBiologicalProcess | muscle cell differentiation | ANK2 ATG7 KLF5 CTDP1 ADGRB3 CASP1 SRF FOXP1 MYO18B CDH2 MEF2A | 1.01e-05 | 531 | 84 | 11 | GO:0042692 |
| GeneOntologyBiologicalProcess | cardiac muscle cell development | 1.06e-05 | 122 | 84 | 6 | GO:0055013 | |
| GeneOntologyBiologicalProcess | cardiac cell development | 1.66e-05 | 132 | 84 | 6 | GO:0055006 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 8.57e-05 | 177 | 84 | 6 | GO:0055007 | |
| GeneOntologyBiologicalProcess | muscle cell development | 9.03e-05 | 259 | 84 | 7 | GO:0055001 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.40e-04 | 25 | 85 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | axoneme | 2.00e-04 | 207 | 85 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 2.05e-04 | 208 | 85 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | microtubule associated complex | 5.09e-04 | 161 | 85 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | inner dynein arm | 7.20e-04 | 10 | 85 | 2 | GO:0036156 | |
| Domain | DUF4599 | 1.62e-05 | 12 | 80 | 3 | PF15371 | |
| Domain | DUF4599 | 1.62e-05 | 12 | 80 | 3 | IPR027970 | |
| Domain | Dynein_HC_stalk | 2.66e-05 | 14 | 80 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.66e-05 | 14 | 80 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.66e-05 | 14 | 80 | 3 | PF08393 | |
| Domain | MT | 2.66e-05 | 14 | 80 | 3 | PF12777 | |
| Domain | DHC_fam | 3.32e-05 | 15 | 80 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 3.32e-05 | 15 | 80 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 3.32e-05 | 15 | 80 | 3 | PF03028 | |
| Domain | MADS | 2.69e-04 | 6 | 80 | 2 | SM00432 | |
| Domain | MADS_BOX_1 | 2.69e-04 | 6 | 80 | 2 | PS00350 | |
| Domain | SRF-TF | 2.69e-04 | 6 | 80 | 2 | PF00319 | |
| Domain | MADS_BOX_2 | 2.69e-04 | 6 | 80 | 2 | PS50066 | |
| Domain | TF_MADSbox | 3.75e-04 | 7 | 80 | 2 | IPR002100 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.59e-03 | 14 | 80 | 2 | IPR024317 | |
| Domain | AAA_8 | 1.59e-03 | 14 | 80 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.59e-03 | 14 | 80 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.59e-03 | 14 | 80 | 2 | PF07728 | |
| Domain | GTP_binding_domain | 2.96e-03 | 19 | 80 | 2 | IPR006073 | |
| Domain | BRCT | 2.96e-03 | 19 | 80 | 2 | PF00533 | |
| Domain | Tyr_Pase_AS | 3.79e-03 | 73 | 80 | 3 | IPR016130 | |
| Domain | BRCT | 3.96e-03 | 22 | 80 | 2 | SM00292 | |
| Domain | Actinin_actin-bd_CS | 4.32e-03 | 23 | 80 | 2 | IPR001589 | |
| Domain | Spectrin | 4.32e-03 | 23 | 80 | 2 | PF00435 | |
| Domain | ACTININ_2 | 4.32e-03 | 23 | 80 | 2 | PS00020 | |
| Domain | ACTININ_1 | 4.32e-03 | 23 | 80 | 2 | PS00019 | |
| Domain | - | 4.32e-03 | 23 | 80 | 2 | 3.40.50.10190 | |
| Domain | BRCT | 5.51e-03 | 26 | 80 | 2 | PS50172 | |
| Domain | BRCT_dom | 6.37e-03 | 28 | 80 | 2 | IPR001357 | |
| Domain | Spectrin_repeat | 6.82e-03 | 29 | 80 | 2 | IPR002017 | |
| Domain | - | 7.23e-03 | 92 | 80 | 3 | 3.90.190.10 | |
| Domain | - | 7.29e-03 | 30 | 80 | 2 | 1.20.1270.60 | |
| Domain | AH/BAR-dom | 7.29e-03 | 30 | 80 | 2 | IPR027267 | |
| Domain | Spectrin/alpha-actinin | 8.27e-03 | 32 | 80 | 2 | IPR018159 | |
| Domain | SPEC | 8.27e-03 | 32 | 80 | 2 | SM00150 | |
| Pathway | REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION | 1.54e-04 | 5 | 56 | 2 | M27825 | |
| Pathway | WP_ADIPOGENESIS | 1.68e-04 | 131 | 56 | 5 | M39505 | |
| Pathway | WP_ADIPOGENESIS_GENES | 2.07e-04 | 137 | 56 | 5 | MM15970 | |
| Pathway | REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION | 2.30e-04 | 6 | 56 | 2 | MM15534 | |
| Pubmed | 5.21e-10 | 6 | 86 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 5.21e-10 | 6 | 86 | 4 | 25930072 | |
| Pubmed | 3.37e-09 | 24 | 86 | 5 | 32212159 | ||
| Pubmed | Switching of α-Catenin From Epithelial to Neuronal Type During Lens Epithelial Cell Differentiation. | 1.21e-06 | 9 | 86 | 3 | 28692740 | |
| Pubmed | 1.65e-06 | 329 | 86 | 8 | 17474147 | ||
| Pubmed | 2.37e-06 | 11 | 86 | 3 | 36125128 | ||
| Pubmed | Transforming growth factor Beta2 is required for valve remodeling during heart development. | 3.16e-06 | 12 | 86 | 3 | 21780244 | |
| Pubmed | 4.01e-06 | 497 | 86 | 9 | 23414517 | ||
| Pubmed | ABR ANK2 EHMT2 N4BP2 SH3GL2 SEC16A ADGRB3 DCHS1 MPDZ CDH2 CEP170B AKAP12 | 4.42e-06 | 963 | 86 | 12 | 28671696 | |
| Pubmed | 4.77e-06 | 268 | 86 | 7 | 33640491 | ||
| Pubmed | G9A promotes tumor cell growth and invasion by silencing CASP1 in non-small-cell lung cancer cells. | 6.04e-06 | 2 | 86 | 2 | 28383547 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 38673806 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 28739802 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 35403677 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 30747104 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 20086047 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 38483114 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 N4BP2 SEC16A ZNF629 MPDZ CRTC1 WWTR1 UNC45A PTPN21 UTRN CEP170B | 9.07e-06 | 861 | 86 | 11 | 36931259 |
| Pubmed | Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. | 1.81e-05 | 3 | 86 | 2 | 18850007 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 15728583 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 32187044 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 9786846 | ||
| Pubmed | MRTF/SRF dependent transcriptional regulation of TAZ in breast cancer cells. | 1.81e-05 | 3 | 86 | 2 | 26885614 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 22045023 | ||
| Pubmed | DeltaEF1 mediates TGF-beta signaling in vascular smooth muscle cell differentiation. | 1.81e-05 | 3 | 86 | 2 | 16824956 | |
| Pubmed | Biomarkers of Barrett's Esophagus: From the Laboratory to Clinical Practice. | 1.81e-05 | 3 | 86 | 2 | 29713984 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 39108258 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 34711824 | ||
| Pubmed | Dystrophin involvement in peripheral circadian SRF signalling. | 1.81e-05 | 3 | 86 | 2 | 34389686 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 23382855 | ||
| Pubmed | Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. | 2.17e-05 | 22 | 86 | 3 | 9324354 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.73e-05 | 351 | 86 | 7 | 38297188 | |
| Pubmed | 3.23e-05 | 25 | 86 | 3 | 21145499 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 23362262 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 30367168 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 38744820 | ||
| Pubmed | TGFβ-TAZ/SRF signalling regulates vascular smooth muscle cell differentiation. | 3.61e-05 | 4 | 86 | 2 | 28342289 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 21532575 | ||
| Pubmed | Activin A, B, and AB increase human trophoblast cell invasion by up-regulating N-cadherin. | 3.61e-05 | 4 | 86 | 2 | 25105734 | |
| Pubmed | Plasma membrane-cytoskeleton-endoplasmic reticulum complexes in neurons and astrocytes. | 3.61e-05 | 4 | 86 | 2 | 14593108 | |
| Pubmed | TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters. | 3.61e-05 | 4 | 86 | 2 | 12061776 | |
| Pubmed | The steroid receptor co-activator-1 (SRC-1) potentiates TGF-beta/Smad signaling: role of p300/CBP. | 3.61e-05 | 4 | 86 | 2 | 15688032 | |
| Pubmed | 4.42e-05 | 156 | 86 | 5 | 22952844 | ||
| Pubmed | p300 cooperates with Smad3/4 and Runx3 in TGFbeta1-induced IgA isotype expression. | 6.01e-05 | 5 | 86 | 2 | 14635047 | |
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 37772772 | ||
| Pubmed | Sec8 modulates TGF-β induced EMT by controlling N-cadherin via regulation of Smad3/4. | 6.01e-05 | 5 | 86 | 2 | 27769780 | |
| Pubmed | The spectrin-ankyrin skeleton controls CD45 surface display and interleukin-2 production. | 6.01e-05 | 5 | 86 | 2 | 12354383 | |
| Pubmed | Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in mice. | 6.01e-05 | 5 | 86 | 2 | 32400277 | |
| Pubmed | Cell phenotypic plasticity requires autophagic flux driven by YAP/TAZ mechanotransduction. | 6.01e-05 | 5 | 86 | 2 | 31416916 | |
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 9199196 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 21965288 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 27497248 | ||
| Pubmed | The Noncanonical Role of ULK/ATG1 in ER-to-Golgi Trafficking Is Essential for Cellular Homeostasis. | 6.01e-05 | 5 | 86 | 2 | 27203176 | |
| Pubmed | TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. | 6.01e-05 | 5 | 86 | 2 | 18568018 | |
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 27155083 | ||
| Pubmed | 8.18e-05 | 418 | 86 | 7 | 34709266 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 28976962 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 27721022 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 37047400 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 12714519 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 23109710 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 21768350 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 19506035 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 34088666 | ||
| Pubmed | Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins. | 9.01e-05 | 6 | 86 | 2 | 11160896 | |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 16423881 | ||
| Pubmed | Large-scale identification of mammalian proteins localized to nuclear sub-compartments. | 1.16e-04 | 38 | 86 | 3 | 11555636 | |
| Pubmed | Differential expression of individual gamma-protocadherins during mouse brain development. | 1.26e-04 | 7 | 86 | 2 | 15964765 | |
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 9256245 | ||
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 15272007 | ||
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 22444631 | ||
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 19723622 | ||
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 18617520 | ||
| Pubmed | 1.68e-04 | 8 | 86 | 2 | 21041365 | ||
| Pubmed | Requirement for core 2 O-glycans for optimal resistance to helminth infection. | 1.68e-04 | 8 | 86 | 2 | 23555902 | |
| Pubmed | 1.68e-04 | 8 | 86 | 2 | 19419955 | ||
| Pubmed | 1.68e-04 | 8 | 86 | 2 | 10531362 | ||
| Pubmed | 1.75e-04 | 209 | 86 | 5 | 36779422 | ||
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 1.87e-04 | 212 | 86 | 5 | 33462405 | |
| Pubmed | 2.15e-04 | 9 | 86 | 2 | 24121790 | ||
| Pubmed | HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers. | 2.15e-04 | 9 | 86 | 2 | 29558368 | |
| Pubmed | 2.15e-04 | 9 | 86 | 2 | 29920846 | ||
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 2.15e-04 | 9 | 86 | 2 | 17884088 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 2.68e-04 | 10 | 86 | 2 | 22159418 | |
| Pubmed | 2.68e-04 | 10 | 86 | 2 | 15138260 | ||
| Pubmed | 2.68e-04 | 10 | 86 | 2 | 31959973 | ||
| Pubmed | 2.68e-04 | 10 | 86 | 2 | 39028807 | ||
| Pubmed | 2.68e-04 | 10 | 86 | 2 | 35200715 | ||
| Pubmed | 2.68e-04 | 10 | 86 | 2 | 11978849 | ||
| Pubmed | 2.90e-04 | 233 | 86 | 5 | 37704626 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CNNM4 ABR ATRX ATG7 SPTB SRF BARD1 FOXP1 UTRN ICA1L MEF2A CEP170B | 2.96e-04 | 1489 | 86 | 12 | 28611215 |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 3.01e-04 | 235 | 86 | 5 | 28378594 | |
| Pubmed | LDLRAP1 UBE4A ANK2 ATRX EHMT2 DROSHA SPTB USP32 ADGRB3 REV3L UTRN | 3.25e-04 | 1285 | 86 | 11 | 35914814 | |
| Pubmed | 3.28e-04 | 11 | 86 | 2 | 22510689 | ||
| Pubmed | Mechanical feedback defines organizing centers to drive digit emergence. | 3.28e-04 | 11 | 86 | 2 | 35413235 | |
| Pubmed | Dchs1-Fat4 regulation of osteogenic differentiation in mouse. | 3.28e-04 | 11 | 86 | 2 | 31358536 | |
| Pubmed | 3.28e-04 | 11 | 86 | 2 | 19429912 | ||
| Pubmed | Versican facilitates chondrocyte differentiation and regulates joint morphogenesis. | 3.28e-04 | 11 | 86 | 2 | 20404343 | |
| Pubmed | 3.28e-04 | 11 | 86 | 2 | 22498737 | ||
| Pubmed | 3.28e-04 | 11 | 86 | 2 | 10847592 | ||
| Interaction | TEAD1 interactions | 5.93e-07 | 176 | 82 | 8 | int:TEAD1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 9.64e-05 | 8 | 86 | 2 | chr9q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 3.77e-04 | 503 | 86 | 6 | chr6p21 | |
| Cytoband | 9p13.1 | 9.32e-04 | 24 | 86 | 2 | 9p13.1 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 8.38e-05 | 5 | 53 | 2 | 1086 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 8.64e-04 | 15 | 53 | 2 | 903 | |
| GeneFamily | Dyneins, axonemal | 1.11e-03 | 17 | 53 | 2 | 536 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 ATRX BAZ1A U2SURP BARD1 NCOA1 WWTR1 SSBP2 REV3L CDH2 MEF2A CREB5 IL7R SMAD3 | 5.37e-07 | 856 | 84 | 14 | M4500 |
| CoexpressionAtlas | alpha beta T cells, T.4+8int.Th, 4+ 8int TCRhi, Thymus, avg-3 | 2.61e-05 | 302 | 84 | 8 | GSM399362_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | RSPH3 ANK2 ADGRB3 DCHS1 AKNA NCOA1 GCDH WWTR1 SSBP2 RUNX3 CDH2 CREB5 | 2.99e-05 | 732 | 84 | 12 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_100 | 3.90e-05 | 17 | 84 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_100_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.55e-05 | 103 | 84 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.60e-05 | 247 | 84 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | RSPH3 ANK2 BAZ1A ADGRB3 AKNA NCOA1 GCDH WWTR1 SSBP2 RUNX3 CREB5 | 5.62e-05 | 659 | 84 | 11 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | RSPH3 ANK2 BAZ1A ADGRB3 AKNA NCOA1 GCDH WWTR1 SSBP2 RUNX3 CREB5 | 8.26e-05 | 688 | 84 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3 | 1.35e-04 | 382 | 84 | 8 | GSM476684_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | RSPH3 ANK2 BAZ1A ADGRB3 AKNA NCOA1 GCDH WWTR1 SSBP2 RUNX3 CREB5 | 1.70e-04 | 747 | 84 | 11 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp.TCRbko, TCRd+ Vg2- CD44-, Spleen, avg-3 | 2.01e-04 | 405 | 84 | 8 | GSM605796_500 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.34e-08 | 192 | 86 | 7 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-06 | 184 | 86 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-06 | 189 | 86 | 6 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-06 | 192 | 86 | 6 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-06 | 193 | 86 | 6 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-06 | 193 | 86 | 6 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-06 | 194 | 86 | 6 | b0c15e7e4bcf30856fb628dedd7ba82df33489f5 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.16e-06 | 195 | 86 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.16e-06 | 195 | 86 | 6 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 195 | 86 | 6 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-06 | 196 | 86 | 6 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.23e-06 | 196 | 86 | 6 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-06 | 196 | 86 | 6 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-06 | 196 | 86 | 6 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-06 | 197 | 86 | 6 | c10dd1aaec01fb662eac83dfde90e3e426665d65 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-06 | 197 | 86 | 6 | 2844dbcd0a673ed81c99920aa45858651a00736d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 198 | 86 | 6 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 198 | 86 | 6 | b027a141ab531d0f5d6a26811a53427e7b0771dd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 198 | 86 | 6 | 31ba87552be97c9b78c9e82f98e96699ccb19824 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 198 | 86 | 6 | 953630dbe3154b1b102b87de0feca2cbf124eabe | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.36e-06 | 198 | 86 | 6 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 198 | 86 | 6 | fa84bf8533d1b91d2c2bcf06b710670605072b89 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 198 | 86 | 6 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 198 | 86 | 6 | 8e45551224fbb30c0658ad47dd98335ecf165437 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.50e-06 | 200 | 86 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 1.47e-05 | 160 | 86 | 5 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.52e-05 | 161 | 86 | 5 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 173 | 86 | 5 | 6397b3fa72e2621a9a0f27f49446de2d3a30e420 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 176 | 86 | 5 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.33e-05 | 176 | 86 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 176 | 86 | 5 | 01774a86d7d92f31a056b753f9844f923038003e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-05 | 179 | 86 | 5 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 182 | 86 | 5 | ef65b095f4240d61cfd4a59aec19d72d324dba1d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 182 | 86 | 5 | 97a805783a1f2b055c21307db250e3688674eff3 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.81e-05 | 183 | 86 | 5 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-05 | 183 | 86 | 5 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 184 | 86 | 5 | e123ad8ee46a032825a0bd4b3586ddcb3eda03d4 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.89e-05 | 184 | 86 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.96e-05 | 185 | 86 | 5 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.96e-05 | 185 | 86 | 5 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.04e-05 | 186 | 86 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 186 | 86 | 5 | ba6ba75218efc26371cea24ddbb0e9b3e3f421ac | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 186 | 86 | 5 | 65e25a9dcef5fc71510aaf170e220deef5b2feb2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 186 | 86 | 5 | e4f1259725160719e5fd13d76e5a707efed70013 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 187 | 86 | 5 | 3548a9914c2b2f5d805798ce22ab26eab6d03897 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 187 | 86 | 5 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 187 | 86 | 5 | f4de4b7af1fdfbd628b1f509c060c1079d2e5437 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 187 | 86 | 5 | 81754e965848b718be20ee97ce072ce426938a69 | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.20e-05 | 188 | 86 | 5 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.20e-05 | 188 | 86 | 5 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 188 | 86 | 5 | c300accbac71a3bc075fe985543d8a8ead82531b | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 3.20e-05 | 188 | 86 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.20e-05 | 188 | 86 | 5 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.28e-05 | 189 | 86 | 5 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.28e-05 | 189 | 86 | 5 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-05 | 189 | 86 | 5 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-05 | 190 | 86 | 5 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 3.36e-05 | 190 | 86 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.36e-05 | 190 | 86 | 5 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-05 | 191 | 86 | 5 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.45e-05 | 191 | 86 | 5 | 054fa0493b00149313c243d39cf39a264044f074 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.54e-05 | 192 | 86 | 5 | 30cefa0990ba1f379f350bfbf994a78db145075e | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.54e-05 | 192 | 86 | 5 | 0e7e55505bd5454d7cf952a63fdcb46ec76f1973 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-05 | 192 | 86 | 5 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 192 | 86 | 5 | 8b625c22dda23c99654c82c529a1233e99e71b54 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-05 | 192 | 86 | 5 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-05 | 193 | 86 | 5 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-05 | 193 | 86 | 5 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-05 | 193 | 86 | 5 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 3.62e-05 | 193 | 86 | 5 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-05 | 193 | 86 | 5 | 025836c5c5a711e477c326559e618e47cae42d11 | |
| ToppCell | T_cell|World / shred by cell class for nasal brushing | 3.62e-05 | 193 | 86 | 5 | 07530bbeffd5951880ed6ea50a962c102b05ccc2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 193 | 86 | 5 | 6a623acd1adad9a78eddc32ffedb16352ad3fdfa | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 193 | 86 | 5 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.71e-05 | 194 | 86 | 5 | 7b6ec45adb7ece3c8a7b78c5782413b5825effe2 | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|Myeloid / Disease state, Lineage and Cell class | 3.71e-05 | 194 | 86 | 5 | 73459ee062ae1f1a3bb9719dc0b89aae10600e22 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-05 | 194 | 86 | 5 | f76808666fb875fc787751cbfd924d9be20a8192 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-05 | 194 | 86 | 5 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|CTRL / Disease state, Lineage and Cell class | 3.71e-05 | 194 | 86 | 5 | 927480f56cccd3940b689f3c40ee132fe3e63745 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-05 | 194 | 86 | 5 | f5706ab6bc803606c4640ddd606617e4e797ccc9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-05 | 194 | 86 | 5 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.76e-05 | 97 | 86 | 4 | f3c3fb260954f594a9ab8e1ac9a01115767cbc7a | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.81e-05 | 195 | 86 | 5 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.81e-05 | 195 | 86 | 5 | dc84a910b6f6eb9994cd683aa4fd813a82198e5f | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-05 | 195 | 86 | 5 | 667a2ed4b865e9a37674b3d154bb5bf2188b3ebf | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 3.81e-05 | 195 | 86 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-05 | 195 | 86 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.81e-05 | 195 | 86 | 5 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-05 | 195 | 86 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 3.81e-05 | 195 | 86 | 5 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 3.90e-05 | 196 | 86 | 5 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.90e-05 | 196 | 86 | 5 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | ASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.90e-05 | 196 | 86 | 5 | 14dd6956ef420b660be0baf52a66960e57d75d16 | |
| ToppCell | ILEUM-non-inflamed-(9)_Enteric_neurons|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.90e-05 | 196 | 86 | 5 | 998aa523555ed6bc9c1b5cacbf7ba77c7b218e6b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.90e-05 | 196 | 86 | 5 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-05 | 196 | 86 | 5 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-05 | 196 | 86 | 5 | 8f2031b1a9232c389517fbf3c29f47f9468b0077 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.90e-05 | 196 | 86 | 5 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-05 | 196 | 86 | 5 | 48b4a9cea97a55190217deaf51bf867608c5a9a7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-05 | 196 | 86 | 5 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| Drug | CID11987713 | 3.88e-07 | 190 | 81 | 8 | CID011987713 | |
| Drug | Practolol [6673-35-4]; Down 200; 15uM; PC3; HT_HG-U133A | 7.06e-06 | 199 | 81 | 7 | 4603_DN | |
| Drug | Gly-His-Lys acetate salt; Down 200; 1uM; PC3; HT_HG-U133A | 7.06e-06 | 199 | 81 | 7 | 6560_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 6.20e-05 | 191 | 81 | 6 | 1063_DN | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 6.57e-05 | 193 | 81 | 6 | 1653_DN | |
| Drug | rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.76e-05 | 194 | 81 | 6 | 5932_DN | |
| Drug | Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; PC3; HT_HG-U133A | 6.76e-05 | 194 | 81 | 6 | 4648_DN | |
| Drug | 17-AAG; Down 200; 1uM; SKMEL5; HG-U133A | 6.96e-05 | 195 | 81 | 6 | 505_DN | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.96e-05 | 195 | 81 | 6 | 6973_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HT_HG-U133A | 6.96e-05 | 195 | 81 | 6 | 4433_DN | |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; HL60; HT_HG-U133A | 7.16e-05 | 196 | 81 | 6 | 1840_UP | |
| Drug | Pregnenolone [145-13-1]; Down 200; 12.6uM; PC3; HT_HG-U133A | 7.16e-05 | 196 | 81 | 6 | 4218_DN | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A | 7.16e-05 | 196 | 81 | 6 | 7369_DN | |
| Drug | CP-319743 [172078-87-4]; Down 200; 10uM; PC3; HT_HG-U133A | 7.16e-05 | 196 | 81 | 6 | 7491_DN | |
| Drug | Hydrocortisone base [50-23-7]; Down 200; 11uM; PC3; HT_HG-U133A | 7.16e-05 | 196 | 81 | 6 | 6684_DN | |
| Drug | Betazole hydrochloride; Down 200; 27uM; PC3; HT_HG-U133A | 7.16e-05 | 196 | 81 | 6 | 6344_DN | |
| Drug | Thiamine hydrochloride [67-03-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 7.16e-05 | 196 | 81 | 6 | 7479_UP | |
| Drug | Thyroxine (L) [51-48-9]; Down 200; 5.2uM; HL60; HT_HG-U133A | 7.16e-05 | 196 | 81 | 6 | 1312_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 7.36e-05 | 197 | 81 | 6 | 1732_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 5605_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 4547_DN | |
| Drug | Xylazine [7361-61-7]; Down 200; 18.2uM; PC3; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 4066_DN | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; PC3; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 4189_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; PC3; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 7293_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; PC3; HT_HG-U133A | 7.57e-05 | 198 | 81 | 6 | 7251_DN | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 7.57e-05 | 198 | 81 | 6 | 5533_DN | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 7.57e-05 | 198 | 81 | 6 | 5479_UP | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; HL60; HT_HG-U133A | 7.57e-05 | 198 | 81 | 6 | 3112_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A | 7.57e-05 | 198 | 81 | 6 | 2700_DN | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 7.57e-05 | 198 | 81 | 6 | 1479_DN | |
| Drug | ICI 182,780; Up 200; 0.01uM; MCF7; HG-U133A | 7.57e-05 | 198 | 81 | 6 | 310_UP | |
| Drug | Torsemide [56211-40-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 7.78e-05 | 199 | 81 | 6 | 5476_UP | |
| Drug | Acemetacin [53164-05-9]; Down 200; 9.6uM; PC3; HT_HG-U133A | 7.78e-05 | 199 | 81 | 6 | 6361_DN | |
| Drug | Hydrocortisone base [50-23-7]; Down 200; 11uM; MCF7; HT_HG-U133A | 8.00e-05 | 200 | 81 | 6 | 5284_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 8.00e-05 | 200 | 81 | 6 | 995_DN | |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; HL60; HT_HG-U133A | 8.00e-05 | 200 | 81 | 6 | 1872_DN | |
| Drug | A25618 | PCDHGC5 EHMT2 SRF NCOA1 FOXP1 MYO18B RUNX3 MEF2A CREB5 AKAP12 SMAD3 | 9.38e-05 | 777 | 81 | 11 | CID000005562 |
| Drug | bronopol | 1.24e-04 | 5 | 81 | 2 | CID000002450 | |
| Disease | urate measurement, bone density | FNDC1 KIF6 WDR64 EHMT2 CD34 SEC16A ADGRB3 CRTC1 DNAH8 UTRN AKAP12 | 1.15e-06 | 619 | 82 | 11 | EFO_0003923, EFO_0004531 |
| Disease | Carcinoma, Ovarian Epithelial | 7.96e-05 | 30 | 82 | 3 | C4721610 | |
| Disease | Colorectal Carcinoma | 1.45e-04 | 702 | 82 | 9 | C0009402 | |
| Disease | gastroesophageal reflux disease | 1.84e-04 | 101 | 82 | 4 | EFO_0003948 | |
| Disease | underweight body mass index status | 2.71e-04 | 9 | 82 | 2 | EFO_0005936 | |
| Disease | Uterine Cancer | 3.38e-04 | 10 | 82 | 2 | C0153567 | |
| Disease | thiamine measurement | 3.38e-04 | 10 | 82 | 2 | EFO_0010540 | |
| Disease | central corneal thickness, intraocular pressure measurement | 4.13e-04 | 11 | 82 | 2 | EFO_0004695, EFO_0005213 | |
| Disease | Nasal Cavity Polyp | 4.89e-04 | 55 | 82 | 3 | EFO_1000391 | |
| Disease | thyroid gland carcinoma (is_marker_for) | 4.94e-04 | 12 | 82 | 2 | DOID:3963 (is_marker_for) | |
| Disease | reticulocyte measurement | 6.70e-04 | 1053 | 82 | 10 | EFO_0010700 | |
| Disease | Adenocarcinoma Of Esophagus | 6.79e-04 | 14 | 82 | 2 | C0279628 | |
| Disease | Hiatus hernia | 6.79e-04 | 14 | 82 | 2 | HP_0002036 | |
| Disease | allergic disease | 7.75e-04 | 258 | 82 | 5 | MONDO_0005271 | |
| Disease | testosterone measurement | DOCK4 UBE4A ANK2 NICN1 ZNF629 AKNA NCOA1 FOXP1 PTPN21 UTRN JPT2 | 7.89e-04 | 1275 | 82 | 11 | EFO_0004908 |
| Disease | keratoconus | 8.34e-04 | 66 | 82 | 3 | MONDO_0015486 | |
| Disease | squamous cell carcinoma | 8.72e-04 | 67 | 82 | 3 | EFO_0000707 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 8.93e-04 | 16 | 82 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | glutarylcarnitine (C5-DC) measurement | 1.01e-03 | 17 | 82 | 2 | EFO_0800030 | |
| Disease | rhinitis | 1.01e-03 | 17 | 82 | 2 | EFO_0008521 | |
| Disease | esophageal adenocarcinoma, digestive system disease, Barrett's esophagus | 1.13e-03 | 18 | 82 | 2 | EFO_0000280, EFO_0000405, EFO_0000478 | |
| Disease | esophageal adenocarcinoma | 1.13e-03 | 18 | 82 | 2 | EFO_0000478 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.21e-03 | 75 | 82 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | asthma, allergic disease | 1.40e-03 | 79 | 82 | 3 | MONDO_0004979, MONDO_0005271 | |
| Disease | colorectal cancer | 1.47e-03 | 604 | 82 | 7 | MONDO_0005575 | |
| Disease | leptin measurement | 1.51e-03 | 81 | 82 | 3 | EFO_0005000 | |
| Disease | diaphragmatic hernia | 1.55e-03 | 21 | 82 | 2 | EFO_0008561 | |
| Disease | congestive heart failure (is_marker_for) | 1.56e-03 | 82 | 82 | 3 | DOID:6000 (is_marker_for) | |
| Disease | balding measurement | 1.61e-03 | 792 | 82 | 8 | EFO_0007825 | |
| Disease | corneal resistance factor | 1.62e-03 | 451 | 82 | 6 | EFO_0010067 | |
| Disease | psoriatic arthritis | 1.85e-03 | 87 | 82 | 3 | EFO_0003778 | |
| Disease | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement | 2.02e-03 | 24 | 82 | 2 | EFO_0006821, EFO_0006826 | |
| Disease | ankylosing spondylitis | 2.11e-03 | 91 | 82 | 3 | EFO_0003898 | |
| Disease | FEV/FEC ratio | ABR CNTN5 U2SURP KIAA0586 CRTC1 FOXP1 WWTR1 RUNX3 IL7R SMAD3 | 2.12e-03 | 1228 | 82 | 10 | EFO_0004713 |
| Disease | atopic asthma | 2.33e-03 | 199 | 82 | 4 | EFO_0010638 | |
| Disease | unipolar depression, depressive symptom measurement | 2.37e-03 | 26 | 82 | 2 | EFO_0003761, EFO_0007006 | |
| Disease | white matter integrity, age at assessment | 2.37e-03 | 26 | 82 | 2 | EFO_0004641, EFO_0008007 | |
| Disease | optic disc size measurement | 2.59e-03 | 205 | 82 | 4 | EFO_0004832 | |
| Disease | upper respiratory tract disorder | 2.75e-03 | 28 | 82 | 2 | MONDO_0004867 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 2.75e-03 | 28 | 82 | 2 | DOID:1094 (implicated_via_orthology) | |
| Disease | Barrett's esophagus | 2.75e-03 | 28 | 82 | 2 | EFO_0000280 | |
| Disease | Pancreatic Neoplasm | 2.76e-03 | 100 | 82 | 3 | C0030297 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QENMSSRTDSPIPPF | 26 | A8MT66 | |
| DESPTMSPQLSARSQ | 51 | Q12979 | |
| TGDMNAPPGSRESQT | 326 | Q9Y5B0 | |
| SNMSDEFISLSPGTP | 381 | Q99728 | |
| SLVNMSTPDPDANGL | 2176 | P13611 | |
| FRDIPNTSSMENPAP | 1451 | O60242 | |
| MGAGSSTEQRSPEQP | 1 | Q02952 | |
| ESRAMENQYSPTPGT | 636 | Q9NPY3 | |
| DVPGRADTSQPSARM | 571 | Q96KQ7 | |
| EPTEETFNPMSQLAR | 41 | A0A0U1RR37 | |
| LSGPFMDPTQDQRST | 956 | Q96M86 | |
| VPPGSLNSRDFDQNM | 1396 | Q9Y4F5 | |
| EPLMSESTSNIDQGP | 861 | Q9NRL2 | |
| TGDPSTPSRMIRTNE | 756 | O94779 | |
| PPMVNVTRSEASEGN | 206 | Q29983 | |
| TNMDEVPRPQALSGS | 231 | Q5SW96 | |
| PSSMDSNSSPEEVQF | 2696 | Q01484 | |
| TDNMLSDQTPTPTRF | 51 | Q02930 | |
| PEGQDPQTLTMLRAS | 1761 | Q96JQ0 | |
| STVPFRNPDENSRGM | 241 | P16150 | |
| MKSFPSRSPSQGDED | 586 | Q9Y216 | |
| SDNFFRMGSSPLEVP | 521 | Q8NCE2 | |
| NRMASNIFGPTEEPQ | 41 | Q9H910 | |
| MEPPQETNRPFSTLD | 1 | Q53TS8 | |
| LNDNSPSFATPEREM | 126 | Q9Y5F6 | |
| FDQSMARSEKSPLPQ | 3716 | Q96JB1 | |
| NESDSSPGRSPMQAV | 616 | Q9H334 | |
| PEEGQRMRLSSAPSQ | 516 | Q6ZMV9 | |
| QTDSAMEPTGPTQER | 341 | P36915 | |
| FRTPEINNSSGEMDP | 226 | P16871 | |
| TRMPGFQTPSEFLEN | 101 | Q96FB5 | |
| PRQEMGRSPVDSLSS | 446 | Q02078 | |
| SSNPSITGSDVMRPD | 416 | Q16825 | |
| TPSDGQSMERAESPT | 116 | Q86VX9 | |
| PSGTQPFSSNEQEMS | 396 | B2RXH4 | |
| PFSSNEQEMSPTRTE | 401 | B2RXH4 | |
| ETSSPPRLAMNQNTD | 31 | P46100 | |
| SSSDDRMNEPPTSLG | 606 | O95352 | |
| SFEQPDGRAQMPTTE | 376 | P29466 | |
| SESSDEVFNMQPSPS | 1661 | Q8N1I0 | |
| TFPGSRPMSPEQQLD | 196 | Q8TD57 | |
| EPNSGSDPSSMETRA | 181 | Q92947 | |
| SRPEFPETPNTDLMQ | 161 | I3L273 | |
| MDLPFQTPFQSSGLD | 76 | Q6UUV9 | |
| LGSREDSPMSPSDTQ | 546 | Q4ZHG4 | |
| STPVDMPSRGQNEDR | 221 | Q9P278 | |
| RATPMEFQDSSAPPA | 256 | Q7Z591 | |
| MDSFGQPRPEDNQSV | 1 | Q8NDH6 | |
| PSPNMFTINNETGDI | 316 | P19022 | |
| MSLDNNGTATPELPT | 31 | P28906 | |
| NDFSPVEPNSSSLME | 536 | Q96DY7 | |
| EPRTSEEPGSITNSM | 1441 | P56715 | |
| NSPTALSTPGRMDEA | 396 | Q13761 | |
| RSSPPTTAGTEEAMN | 351 | C9JL84 | |
| MSQPSAPDFVQRGFD | 866 | P46939 | |
| INIMSRLGQDDPTPS | 946 | Q9NRR4 | |
| SLSNQPGTPRDDGEM | 326 | P81877 | |
| QDPQEPSARSEGLSM | 321 | Q6IN84 | |
| LSPQDDTNSGMSIPR | 371 | Q15788 | |
| GETPQNLSRDMKSFP | 676 | Q8IWB4 | |
| GLPDPSRVSSEVQQM | 166 | Q9BSH3 | |
| MGANTSRKPPVFDEN | 1 | Q8WU08 | |
| PRSDPTTDQRMSATG | 226 | P11831 | |
| FEPPQSDSDGQRRSM | 231 | O15042 | |
| AQQDFQLSSGSPPEM | 156 | A8MTZ7 | |
| LASRMENSPQFPIDG | 721 | Q6P4Q7 | |
| GETPQNLSRDMKSFP | 676 | Q5VYP0 | |
| DMPTRTAPGESAFRN | 246 | Q96PP4 | |
| SQPPRGMGSFREDSV | 241 | Q8TCY9 | |
| RGSQPPDMASALTDR | 136 | Q86UC2 | |
| RQDENTPSVDISMGP | 911 | O75970 | |
| VSRNNDMLTPTPDSS | 1841 | O60673 | |
| GETPQNLSRDMKSFP | 676 | Q5TZJ5 | |
| PEEAMSGQQSRNPSS | 761 | O15027 | |
| AMFSELSNPESLPAQ | 1076 | O15027 | |
| GETPQNLSRDMKSFP | 676 | Q5VU36 | |
| SQPSMTVDGFTDPSN | 251 | P84022 | |
| MSLEFPTGDSTQPNG | 261 | Q99962 | |
| MTSATEFENVGNQPP | 1 | P11277 | |
| GSRSPDPEQMTSING | 111 | Q8IUG5 | |
| DQTDPFNRSPLTMDQ | 1026 | Q14139 | |
| MSLERSSQDPSVPQN | 61 | Q9UEG4 | |
| DPPGELAVTANSRMS | 356 | Q9H3U1 | |
| NEMFTLTTNGDLPRP | 1021 | Q8NFA0 | |
| APSQQQVSPGDMDRT | 1456 | Q9BVV6 | |
| ERNFSQPTDNPTMDL | 631 | B1ANS9 | |
| PDMRSITNNSSDPFL | 286 | Q9GZV5 | |
| SSEPGSPDRQAEMLQ | 306 | Q13887 | |
| SSEFINPDSSNMTPI | 176 | Q86UW6 |